| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2010 | US20100087426 Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds |
| 04/08/2010 | US20100087425 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors |
| 04/08/2010 | US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents |
| 04/08/2010 | US20100087423 New benzamide derivatives as bradykinin antagonists |
| 04/08/2010 | US20100087422 Treatment of adhd |
| 04/08/2010 | US20100087421 Method to determine the risk for side effects of an ssri treatment in a person |
| 04/08/2010 | US20100087420 Heterotricyclic Metalloprotease Inhibitors |
| 04/08/2010 | US20100087419 Hiv integrase inhibitors |
| 04/08/2010 | US20100087418 Benzoxazepine derivatives and use thereof |
| 04/08/2010 | US20100087417 Amino-pyridine derivatives as s1p1 /edg1 receptor agonists |
| 04/08/2010 | US20100087416 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 04/08/2010 | US20100087415 Inhibitors of store operated calcium release |
| 04/08/2010 | US20100087414 Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide |
| 04/08/2010 | US20100087413 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| 04/08/2010 | US20100087412 Micronized Eplerenone Compositions |
| 04/08/2010 | US20100087411 Substituted sapogenins and their use |
| 04/08/2010 | US20100087410 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 04/08/2010 | US20100087409 Composition comprising an antibiotic and a corticosteroid |
| 04/08/2010 | US20100087408 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE |
| 04/08/2010 | US20100087407 use of aromatase inhibitors |
| 04/08/2010 | US20100087406 Induction of innate immunity by vitamin d3 and its analogs |
| 04/08/2010 | US20100087405 Food supplementation composition containing one or more vitamin d3 compounds and one or more magnesium salts |
| 04/08/2010 | US20100087404 Method of treating and preventing hyperparathyroidism with active vitamin d analogs |
| 04/08/2010 | US20100087403 Topical treatment of skin infection |
| 04/08/2010 | US20100087402 Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
| 04/08/2010 | US20100087401 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| 04/08/2010 | US20100087400 Beta-Hydroxy-Gamma-Aminophosphonates and Methods for the Preparation and Use Thereof |
| 04/08/2010 | US20100087399 Use of 9-oxoacridine-10-acetic acid, salts and esters thereof in combination therapy of ovarian cancer |
| 04/08/2010 | US20100087398 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions |
| 04/08/2010 | US20100087397 Use of lipid conjugates in the treatment of conjunctivitis |
| 04/08/2010 | US20100087396 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/08/2010 | US20100087395 Cosmetic preparation |
| 04/08/2010 | US20100087394 Compositions Containing Betaine and Hydrophobic Silica |
| 04/08/2010 | US20100087393 Methods and compositions of inhibiting complement and cellular activation with dextran sulfate |
| 04/08/2010 | US20100087392 Complexes of ibuprofen, cyclodextrins and ternary agents and the use thereof in pharmaceutics |
| 04/08/2010 | US20100087391 Treatment of inflammatory bowel disease |
| 04/08/2010 | US20100087390 Universal Sensory Structurant |
| 04/08/2010 | US20100087389 Sensory Modifier |
| 04/08/2010 | US20100087388 Odcase inhibitors as anti-virals and antibiotics |
| 04/08/2010 | US20100087387 Five- and six-membered conformationally locked 2',4'-carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 04/08/2010 | US20100087386 Topical use of levofloxacin for reducing lung inflammation |
| 04/08/2010 | US20100087385 Application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease |
| 04/08/2010 | US20100087384 Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases |
| 04/08/2010 | US20100087374 Methods for Treatment and Diagnosis of Pulmonary Diseases Based on the Expression of SERCA2 Protein |
| 04/08/2010 | US20100087370 Modulation of nitric oxide signaling to normalize tumor vasculature |
| 04/08/2010 | US20100087369 Composition comprising oligogalacturonans and polycationic saccharides |
| 04/08/2010 | US20100087364 Tropine modulators of 5-ht3 receptor |
| 04/08/2010 | US20100087360 Heterocycle-substituted benzimidazole derivative |
| 04/08/2010 | US20100087358 NOTCH mutations leading to increased receptor signaling |
| 04/08/2010 | US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 04/08/2010 | US20100086627 Methods and formulations for treating chronic liver disease |
| 04/08/2010 | US20100086624 Colon cleansing compositions and methods |
| 04/08/2010 | US20100086622 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| 04/08/2010 | US20100086615 Agent for treatment of pulmonary disease |
| 04/08/2010 | US20100086614 Nanoparticulated anesthetic composition for topic use |
| 04/08/2010 | US20100086611 Method for Treating Infectious Organisms Normally Considered to be Resistant to an Antimicrobial Drug |
| 04/08/2010 | US20100086610 Vault and vault-like carrier molecules |
| 04/08/2010 | US20100086609 Methods and Compositions for Delivering Peptides |
| 04/08/2010 | US20100086608 Methods and Devices for Detecting Binding Events via Zeta-Potential and Pharmacologically Active Compounds and Delivery Systems Identified Thereby |
| 04/08/2010 | US20100086606 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same |
| 04/08/2010 | US20100086605 Material, item and products comprising a composition having anti-microbial properties |
| 04/08/2010 | US20100086602 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 04/08/2010 | US20100086601 Modified Calcium Phosphate Nanoparticle Formation |
| 04/08/2010 | US20100086599 Oral modified release formulations |
| 04/08/2010 | US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/08/2010 | US20100086594 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/08/2010 | US20100086593 Dosage forms of bisphosphonates |
| 04/08/2010 | US20100086592 Modified dosage forms of tacrolimus |
| 04/08/2010 | US20100086590 Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
| 04/08/2010 | US20100086589 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 04/08/2010 | US20100086588 Compositions and methods for treatment of bowel diseases with granulated mesalamine |
| 04/08/2010 | US20100086586 Pharmaceutical Composition |
| 04/08/2010 | US20100086583 Lipid-analogous phosphoric triesters |
| 04/08/2010 | US20100086582 Amorphous rotigotine transdermal system |
| 04/08/2010 | US20100086581 Method for purpura reduction and prevention |
| 04/08/2010 | US20100086579 Macrocyclic lactone compounds and methods for their use |
| 04/08/2010 | US20100086573 Composition and method for preparing stable unilamellar liposomal suspension |
| 04/08/2010 | US20100086572 Rational ppi dosage forms |
| 04/08/2010 | US20100086565 Vectors for expression of hml-2 polypeptides |
| 04/08/2010 | US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant |
| 04/08/2010 | US20100086553 Antitumor agent |
| 04/08/2010 | US20100086551 Antibody and uses thereof |
| 04/08/2010 | US20100086546 Toll-LIke Receptor 4 Deficiency and Downstream Effectors Cause Pulmonary Emphysema |
| 04/08/2010 | US20100086544 Compositions and methods for treating a neoplasm |
| 04/08/2010 | US20100086543 Compositions and methods for treating conditions associated with ceramide biosynthesis |
| 04/08/2010 | US20100086536 Method of Increasing Plasmin Activity through Antiplasmin Conversion |
| 04/08/2010 | US20100086531 METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND Nrf2 TRANSCRIPTION FACTORS |
| 04/08/2010 | US20100086526 Nucleic acid constructs and methods for specific silencing of h19 |
| 04/08/2010 | US20100086519 Treatment of Hepatitis C Infection With Metalloporphyrins |
| 04/08/2010 | US20100086518 Treatment of melanoma |
| 04/08/2010 | US20100086512 Mucomimetic compositions and uses therefore |
| 04/08/2010 | US20100086504 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections |
| 04/08/2010 | US20100086501 Determining Age Ranges of Skin Samples |
| 04/08/2010 | US20100086495 Compositions and methods for enhancing transmucosal delivery |
| 04/08/2010 | US20100086494 Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof |
| 04/08/2010 | US20100086485 Influenza vaccine |
| 04/08/2010 | US20100086483 Method of multidetector computed tomagraphy |
| 04/08/2010 | US20100086482 Divergent synthesis of looped poly(ester)-and poly(ether)-substituted dendrons and dendrimers |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | DE102008037682A1 Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen Use of equipotent doses of local anesthetics or derivatives thereof for the treatment of chronic pain |